Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Lichtin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Cleveland Clinic Journal of Medicine|May 16, 2001
What evaluation should be done for an apparently healthy patient with an increased mean corpuscular volume (MCV)?A E Lichtin
Dental Clinics of North America|July 1, 1996
Antithrombotic, anticoagulant, and thrombolytic agentsG T Terezhalmy, A E Lichtin
Rheumatic Diseases Clinics of North America|May 1, 1997
Hematologic complications of rheumatic disease therapiesC S George, A E Lichtin
Bone Marrow Transplantation|April 1, 1992
Incidence of mixed chimerism using busulfan/cyclophosphamide containing regimens in allogeneic bone marrow transplantationA J Fishleder, B Bolwell, A E Lichtin
JAMA|March 21, 1986
Thrombotic thrombocytopenic purpura with colitis in an elderly womanA E Lichtin, L E Silberstein, A D Schreiber
The European Respiratory Journal|February 2, 2008
Platelet larceny: spurious hypoxaemia due to extreme thrombocytosisA Mehta, A E Lichtin, A Vigg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Diagnosis: Capnocytophaga canimorsus septicemiaS B Mossad, A E Lichtin, G S Hall, et al.
American Journal of Clinical Oncology|December 1, 1995
High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancerM E Kalaycioglu, A E Lichtin, S W Andresen, et al.
Haematologica|January 2, 2008
Hypocupremia and bone marrow failureA S Haddad, V Subbiah, A E Lichtin, et al.
Archives of Internal Medicine|December 1, 1987
Efficacy of intensive plasmapheresis in thrombotic thrombocytopenic purpuraA E Lichtin, A D Schreiber, S Hurwitz, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Cleveland Clinic Journal of Medicine|May 16, 2001
What evaluation should be done for an apparently healthy patient with an increased mean corpuscular volume (MCV)?A E Lichtin
Dental Clinics of North America|July 1, 1996
Antithrombotic, anticoagulant, and thrombolytic agentsG T Terezhalmy, A E Lichtin
Rheumatic Diseases Clinics of North America|May 1, 1997
Hematologic complications of rheumatic disease therapiesC S George, A E Lichtin
Bone Marrow Transplantation|April 1, 1992
Incidence of mixed chimerism using busulfan/cyclophosphamide containing regimens in allogeneic bone marrow transplantationA J Fishleder, B Bolwell, A E Lichtin
JAMA|March 21, 1986
Thrombotic thrombocytopenic purpura with colitis in an elderly womanA E Lichtin, L E Silberstein, A D Schreiber
The European Respiratory Journal|February 2, 2008
Platelet larceny: spurious hypoxaemia due to extreme thrombocytosisA Mehta, A E Lichtin, A Vigg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
Diagnosis: Capnocytophaga canimorsus septicemiaS B Mossad, A E Lichtin, G S Hall, et al.
American Journal of Clinical Oncology|December 1, 1995
High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancerM E Kalaycioglu, A E Lichtin, S W Andresen, et al.
Haematologica|January 2, 2008
Hypocupremia and bone marrow failureA S Haddad, V Subbiah, A E Lichtin, et al.
Archives of Internal Medicine|December 1, 1987
Efficacy of intensive plasmapheresis in thrombotic thrombocytopenic purpuraA E Lichtin, A D Schreiber, S Hurwitz, et al.
Pageof 2